NYSE:SPOT charts & data provided by TradingView

Latest Insights on SPOT

Great Stuff 7-5-2019 Friday Four Play: Good Jobs = Bad News
by Joseph Hargett July 5, 2019 Great Stuff
That was quite the Fourth of July celebration, wasn’t it? The fireworks, the music … and stuff. Freedom was everywhere. It was awesome. I don’t know about you, but I’m beat this morning. Apparently, so is the market. But we’ll get to that in a minute. Next week, I’m going on vacation to celebrate my […]
How to Beat Wall Street at Its Own Game
by Charles Mizrahi July 4, 2019 American Investor Today, Investing, Stocks
There’s a misconception in the investing world. People think that management firms and Wall Street have the upper hand. But Charles Mizrahi explains why that isn’t the case. And he shares with you the reason behind your edge over the big-money firms. (6-minute video)
This indicator follows the trend rather than forecasting the trend. That's the key to profits in 2019, and in every other year. Simple Stock Indicator to Avoid Losses and Spot Great Buys
by Michael Carr July 1, 2019 Recession, Stocks, Trading Strategies, Winning Investor Daily
Following the trend rather than forecasting the trend is the key to profits in 2019, and in every other year.
Great Stuff 7-1-2019 The Trade War Truce Rally: AMD, Apple, Nvidia and Oil?
by Joseph Hargett July 1, 2019 Great Stuff
Today’s G-20 rally is no surprise. There was no way President Donald Trump was coming out of the G-20 meeting without a win — one way or another. And he certainly got a win. I’m not talking about the pause in the trade war — that was a given. It fits Trump’s M.O. to a […]
Great Stuff 06-25-2019 The Real Question for the $63 Billion AbbVie-Allergan Acquisition
by Joseph Hargett June 25, 2019 Great Stuff
I know my brain doesn’t work quite right. I wouldn’t be writing Great Stuff if it did. Today, I’m left with a burning question on AbbVie’s $63 billion cash and stock acquisition of Allergan. It’s not about the viability of the combined company. Both AbbVie Inc. (NYSE: ABBV) and Allergan PLC (NYSE: AGN) face serious […]

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

“Loving this. Should have started a long time ago.”

- Jay

Share This